Seritage Growth Properties — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Seritage Growth Properties filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.20M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $17.62M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.78M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $107.06M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | $116.68M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $116.50M | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | $36.63M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $47.63M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $40.51M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $43.86M | Mar 2, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $607.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $567.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.72M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.45M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | $1.03M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $293.0K | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $1.60M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.20M | Mar 15, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($154.91M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($73.95M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($28.15M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($105.03M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | ($59.40M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | ($73.47M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | ($73.75M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | ($51.56M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | ($22.34M) | Feb 28, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($65.16M) | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | ($18.00M) | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | ($14.67M) | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | ($16.74M) | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | ($10.84M) | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | ($22.77M) | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.77M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $396.0K | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $7.18M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | ($16.55M) | Mar 1, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($53.55M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($53.06M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($117.92M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($136.00M) | Apr 1, 2024 |
| FY2021 | Sep 30, 2021 | ($96.55M) | Mar 16, 2022 |
| FY2021 | Jun 30, 2021 | ($67.60M) | Mar 16, 2022 |
| FY2021 | Mar 31, 2021 | ($23.10M) | Mar 16, 2022 |
| FY2022 | Dec 31, 2020 | ($47.31M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | ($57.66M) | Mar 16, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $393.78M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $677.77M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $973.86M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.84B | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.41B | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.65B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $2.75B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.88B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $2.78B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.71B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.98M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $271.97M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $410.70M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.12B | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.57B | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.77B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.71B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $1.73B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.45B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.29B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $331.42M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $404.46M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $561.99M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $720.47M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $687.74M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $649.04M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $731.42M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $780.77M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $886.70M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $804.56M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.03B) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($958.78M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($800.34M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($640.53M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($553.77M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | ($528.64M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($418.71M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($344.13M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | ($229.76M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($121.34M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.09M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $85.21M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $134.00M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $133.48M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $106.60M | Apr 1, 2024 |
| FY2023 | Dec 31, 2020 | $143.73M | Apr 1, 2024 |
| FY2022 | Dec 31, 2019 | $139.26M | Mar 14, 2023 |
| FY2021 | Dec 31, 2018 | $532.86M | Mar 16, 2022 |
| FY2019 | Dec 31, 2017 | $241.57M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $52.03M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $1.20B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.17B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.14B | Mar 1, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Mar 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 2, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Aug 29, 2018 | 0 | Mar 2, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2019 | $17.96M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $35.68M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $34.25M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $39.35M | Mar 1, 2019 |